Anika Therapeutics's total assets for Q2 2026 were $183.47M, an increase of 2.28% from the previous quarter. CH:AKP total liabilities were $46.19M for the fiscal quarter, a 1.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.